Beta-lactams linked to hemolytic uremic syndrome in children, adults with E. coli

10/17/2013 | Family Practice News

In a study involving 1,308 people with Shiga toxin–producing Escherichia coli 0157 infection, researchers found that treatment with beta-lactam antibiotics and sulfonamides was tied to at least partial postdiarrheal hemolytic uremic syndrome in children and adults. Treatments with any antibiotics and metronidazole were associated with HUS in young patients between ages 5 and 14. The findings were presented at the IDWeek meeting.

View Full Article in:

Family Practice News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA